4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-23-049346
CIK 0001539029other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:55 PM ET
Size
6.9 KB
Accession
0001209191-23-049346
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-09-13$0.40/sh+34,090$13,636→ 397,562 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-09-13−34,090→ 0 totalExercise: $0.40Exp: 2023-11-24→ Common Stock (34,090 underlying)
Footnotes (1)
- [F1]Fully vested and exercisable.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 6:55 PM ET
- Size
- 6.9 KB